klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
XXVII. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Z
Ackermann, S
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Aguirre-Ghiso, JA
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Allen, C
Synthetic diblock copolymer micelles as vectors for siRNA delivery to knockdown RUNX1/ETO in acute myeloid leukaemia cells
Alsadeq, A
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Alten, J
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Arnz, E
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Aumann, K
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Barth, TFE
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Bartram, CR
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Beltinger, C
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Bertele, D
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Blair, H
“In vivo” shRNA screen for the identification of the RUNX1/ETO targets with a relevance in leukaemogenesis
Bonifer, C
A role for Dual Specificity Phosphatase 6 (DUSP6) in the propagation and self-renewal of Acute Myeloid Leukaemia (AML)
Brenner, M
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Brüderlein, S
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Cario, G
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Carlet, M
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Carmichael, A
Identification of genetic alterations in pediatric hepatocellular carcinomas
Coleman, D
Synthetic diblock copolymer micelles as vectors for siRNA delivery to knockdown RUNX1/ETO in acute myeloid leukaemia cells
Dagdan, E
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Debatin, KM
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
Denkhaus, D
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Stratification of infant patients with medulloblastoma: Genomics and biology complement histological classification
Dörge, P
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Dormon, K
Darwinian Evolution of Acute Lymphoblastic Leukaemia
Dorneburg, C
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Dörner, E
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Dreschmann, V
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Eckert, C
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
Eckhoff, SM
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
Eder, M
Bcl2 as a therapeutic target in BCR-ABL positive ALL
Elder, AK
Bcl2 as a therapeutic target in BCR-ABL positive ALL
Engesser, A
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Erlacher, M
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Fedders, H
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Fischer, M
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Fischer, N
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Flotho, C
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Fluhr, S
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
Frühwald, MC
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Fulton, D
Synthetic diblock copolymer micelles as vectors for siRNA delivery to knockdown RUNX1/ETO in acute myeloid leukaemia cells
Garcia, A
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Geley, S
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Geyer, A
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Glassmann, A
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Goschzik, T
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Genetic analysis of adamantinomatous craniopharyngioma (ACP)
Gramlich, A
Investigating the interplay between the Iroquois homeoprotein family and MLL or derivatives thereof
Groebner, SN
Signatures of Mutational Processes in Childhood Cancers
Groeneveld-Krentz, S
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
Grunz, F
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Hapke, M
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Harms, H
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Hasan, N
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
Hasselblatt, M
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Heidenreich, O
A role for Dual Specificity Phosphatase 6 (DUSP6) in the propagation and self-renewal of Acute Myeloid Leukaemia (AML)
“In vivo” shRNA screen for the identification of the RUNX1/ETO targets with a relevance in leukaemogenesis
Establishment of a genome-wide RNAi screen; Identification of novel genes involved in clonal maintenance of ALL
Darwinian Evolution of Acute Lymphoblastic Leukaemia
Bcl2 as a therapeutic target in BCR-ABL positive ALL
Synthetic diblock copolymer micelles as vectors for siRNA delivery to knockdown RUNX1/ETO in acute myeloid leukaemia cells
Heinz, N
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Herbst, J
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Hertwig, F
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Hof, J
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
Hoseini, S
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Houlston, RS
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Hübner, J
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Hutter, S
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Ikram, F
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Jeremias, I
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Jones, DTW
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Kahl, G
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Kahlert, Y
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Kapitza, E
Stratification of infant patients with medulloblastoma: Genomics and biology complement histological classification
Kawauchi, D
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Kirschner-Schwabe, R
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
Klein-Hitpass, L
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Kocak, H
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Koch, I
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Koehler, R
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Köhler, R
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Kollek, M
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Kontny, U
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Kool, M
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Kowarz, E
Investigating the interplay between the Iroquois homeoprotein family and MLL or derivatives thereof
Krämer, A
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Kratz, C
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Krause, S
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Krombholz, CF
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Krombholz, F
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Krüger, A
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Labi, V
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Leuschner, I
Identification of genetic alterations in pediatric hepatocellular carcinomas
Loges, S
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Marschalek, R
Investigating the interplay between the Iroquois homeoprotein family and MLL or derivatives thereof
The MLL recombinome
Martinez-Soria, N
A role for Dual Specificity Phosphatase 6 (DUSP6) in the propagation and self-renewal of Acute Myeloid Leukaemia (AML)
“In vivo” shRNA screen for the identification of the RUNX1/ETO targets with a relevance in leukaemogenesis
Maul, H
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Maurer, U
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
McKenzie, L
A role for Dual Specificity Phosphatase 6 (DUSP6) in the propagation and self-renewal of Acute Myeloid Leukaemia (AML)
Meier, A
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Meyer, C
The MLL recombinome
Meyer, LH
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
Mirjam Eckhoff, S
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Möricke, A
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Müller, HL
Genetic analysis of adamantinomatous craniopharyngioma (ACP)
Müller, S
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Münch, V
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Niemeyer, C
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Niemeyer, CM
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
Northcott, PA
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Obser, T
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Omedes-Pujol, M
Synthetic diblock copolymer micelles as vectors for siRNA delivery to knockdown RUNX1/ETO in acute myeloid leukaemia cells
Oyen, F
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Pal, D
Establishment of a genome-wide RNAi screen; Identification of novel genes involved in clonal maintenance of ALL
Peifer, M
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Pfister, SM
Role of the LIM domain binding protein LDB1 and the LIM only factor LMO4 in SHH subgroup medulloblastoma
Signatures of Mutational Processes in Childhood Cancers
Pietsch, T
Identification of genetic alterations in pediatric hepatocellular carcinomas
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Stratification of infant patients with medulloblastoma: Genomics and biology complement histological classification
Genetic analysis of adamantinomatous craniopharyngioma (ACP)
Piro, RM
Signatures of Mutational Processes in Childhood Cancers
Ponthan, F
Establishment of a genome-wide RNAi screen; Identification of novel genes involved in clonal maintenance of ALL
Pütz, G
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Queudeville, M
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
Rahmann, S
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Reichardt, W
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Roels, F
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Rotter, B
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Rutkowski, S
Stratification of infant patients with medulloblastoma: Genomics and biology complement histological classification
Sauer, M
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Schambach, A
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Scherr, M
Bcl2 as a therapeutic target in BCR-ABL positive ALL
Schewe, D
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Schewe, DM
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Schiedlmeyer, B
Timely controlled T-cell receptor expression against a leukemia-associated antigen for the co-transplantation of MHC-mismatched T-cell precursors into hematopoietic stem cell recipients
Schirmer, M
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
Schlitter, AM
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Schmäh, J
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Schneppenheim, R
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Schrappe, M
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Schulte, JH
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Siebert, R
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Stanulla, M
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Strube, S
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Sürth, J
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Süss, R
Imaged-guided Therapy of Ewing Sarcoma Using targeting Nanoparticles encapsulated with Iron oxide and siRNA against EWS/FLI1
Szymansky, A
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
Teigler-Schlegel, A
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Thomas, R
Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma
Fibroblast growth factor receptors as therapeutic targets in neuroblastoma
Torge, A
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
Trentin, L
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
Identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
vd Brink, M
A caspase gene-based security mechanism for potential leukemogenesis in human cord blood-derived T cell progenitors
Villunger, A
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Voigt, G
Transient apoptosis inhibition in donor cells increases efficacy of hematopoietic stem cell transplantation without increasing the risk of leukemogenesis
Vokuhl, C
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
Identification of genetic alterations in pediatric hepatocellular carcinomas
Vormoor, J
Establishment of a genome-wide RNAi screen; Identification of novel genes involved in clonal maintenance of ALL
Vu-Han, T
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
Wahl, J
CD57high neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients
Winter, P
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
Wohlers, I
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to activation of the NF-kB signalling pathway
Zaliova, M
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Zapatka, M
Signatures of Mutational Processes in Childhood Cancers
Zimmermann, M
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
zur Mühlen, A
Stratification of infant patients with medulloblastoma: Genomics and biology complement histological classification